Journal of the American College of Surgeons
Volume 202, Issue 4 , Pages 588-596 , April 2006

Modern 5-Year Survival of Resectable Esophageal Adenocarcinoma: Single Institution Experience with 263 Patients

Presented at the American College of Surgeons 90th Annual Clinical Congress, New Orleans, LA, October 2004.

  • Giuseppe Portale, MD

      Affiliations

    • Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles, CA
    • ,
  • Jeffrey A. Hagen, MD, FACS

      Affiliations

    • Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles, CA
    • ,
  • Jeffrey H. Peters, MD, FACS

      Affiliations

    • Department of Surgery, University of Rochester, Rochester, NY
    • ,
  • Linda S. Chan, PhD

      Affiliations

    • Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles, CA
    • ,
  • Steven R. DeMeester, MD, FACS

      Affiliations

    • Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles, CA
    • ,
  • Tasha A.K. Gandamihardja, MD

      Affiliations

    • Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles, CA
    • ,
  • Tom R. DeMeester, MD, FACS

      Affiliations

    • Division of Thoracic and Foregut Surgery, University of Southern California, Los Angeles, CA
    • Corresponding Author InformationCorrespondence address: Tom R DeMeester, MD, 1510 San Pablo St, Los Angeles, CA 90033

Received 14 October 2005 ,Revised 29 November 2005 ,Accepted 27 December 2005.

References 

  1. Bedenne L . Randomized phase III trial in locally advanced esophageal cancer (radiochemotherapy followed by surgery versus radiochemotherapy alone (FFCD 9102)) . Orlando, FL: Presented at the Annual Meeting of the American Society of Clinical Oncology; 2002; May 18–21
  2. Kitajima M , Kitagawa Y . Surgical treatment of esophageal cancer. The advent of the era of individualization . N Engl J Med . 2002;347:1705–1708
  3. Altorki N , Skinner D . Should en bloc esophagectomy be the standard of care for esophageal carcinoma? . Ann Surg . 2001;234:581–587
  4. Sihvo EI , Luostarinen ME , Salo JA . Fate of patients with adenocarcinoma of the esophagus and the esophagogastric junction (a population-based analysis) . Am J Gastroenterol . 2004;99:419–424
  5. Hulscher JB , van Sandik JW , De Boer AG , et al.   Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus . N Engl J Med . 2001;21:1663–1669
  6. Hagen JA , DeMeester SR , Peters JH , et al.   Curative resection for esophageal adenocarcinoma (analysis of 100 en bloc esophagectomies) . Ann Surg . 2001;234:520–530
  7. Johansson J , DeMeester TR , Hagen JA , et al.   En bloc vs transhiatal esophagectomy for stage T3N1 adenocarcinoma of the distal esophagus . Arch Surg . 2004;139:627–633
  8. Collard JM , Otte JB , Fiasse R , et al.   Skeletonizing en bloc esophagectomy for cancer . Ann Surg . 2001;234:25–32
  9. Swanson SJ , Batirel HF , Bueno R , et al.   Transthoracic esophagectomy with radical mediastinal and abdominal lymph node dissection and cervical esophagogastrostomy for esophageal carcinoma . Ann Thorac Surg . 2001;72:1918–1924
  10. Rice TW , Blackstone EH , Adelstein DJ , et al.   N1 esophageal carcinoma (the importance of staging and downstaging) . J Thorac Cardiovasc Surg . 2001;121:454–464
  11. Rice TW , Blackstone EH , Rybicki LA , et al.   Role of clinically determined depth of tumor invasion in the treatment of esophageal carcinoma . J Thorac Cardiovasc Surg . 2003;125:1091–1102

 Competing Interests Declared: None.

PII: S1072-7515(06)00002-0

doi: 10.1016/j.jamcollsurg.2005.12.022

Journal of the American College of Surgeons
Volume 202, Issue 4 , Pages 588-596 , April 2006

Article Tools

* Image Usage & Resolution